'%20d='m0%200%2016%2011h61%2061%2061%2061%2060L47%2037h61%2061%2060%2061L16%2063h61%2061%2061%2061%2060L47%2089h61%2061%2060%2061L16%20115h61%2061%2061%2061%2060L47%20141h61%2061%2060%2061L16%20166h61%2061%2061%2061%2060L47%20192h61%2061%2060%2061L16%20218h61%2061%2061%2061%2060z'/%3e%3c/svg%3e)
About
Valerie Lynn Baker, MD, MPP is the Director of the Division of Reproductive Endocrinology and Infertility at the Johns Hopkins University School of Medicine and Telinde-Wallach Professor of Gynecology and Obstetrics. She works in assisted reproductive technology on both the clinical and research side, and her society roles — SART Vice President, past president of SREI, former chair of SART’s research committee — are set out below.
Dr. Baker earned her MD from Harvard Medical School and an MPP from the Harvard Kennedy School of Government, then completed her residency in obstetrics and gynecology and a fellowship in reproductive endocrinology and infertility at UCSF.
Before joining Johns Hopkins, she held faculty positions at UCSF, the University of Washington and Stanford University. She currently serves as Vice President of SART and past President of SREI, playing a leading role in shaping national quality standards in assisted reproduction.
Clinical Expertise
- In Vitro Fertilization (IVF): Full-cycle management from individualized ovarian stimulation protocols to embryo transfer
- Primary Ovarian Insufficiency: Fertility assessment, hormone management and treatment pathways for women with premature ovarian failure
- Fertility Preservation: Oocyte cryopreservation for medical (pre-cancer treatment) and elective (delayed childbearing) indications
- Ovarian Reserve Assessment: AMH, antral follicle count and biomarker-based evaluation to guide treatment decisions
- Long-Term Outcomes Research: Studies on maternal and child health outcomes following fertility treatment
Why Choose Dr. Baker
Industry leadership as SART Vice President: As Vice President of the Society for Assisted Reproductive Technology, Dr. Baker directly shapes national clinical quality standards. Her patients benefit from care built on the most current evidence-based protocols in the field.
Elite academic pedigree: The combination of a Harvard Medical School MD and a Harvard Kennedy School MPP gives her a unique perspective spanning clinical excellence and health policy. She is an associate editor of the American Journal of Obstetrics and Gynecology and Human Reproduction.
Experience across top institutions: Before Johns Hopkins, Dr. Baker practiced at UCSF, the University of Washington and Stanford — three of the country’s leading academic medical centers. This breadth of experience enables her to integrate diverse treatment philosophies for complex cases.
Research leadership: Past President of SREI and former chair of the SART research committee, with over 60 peer-reviewed publications on ovarian stimulation optimization and factors influencing treatment success.
Professional Affiliations
Dr. Baker is board-certified in Reproductive Endocrinology and Infertility. She graduated from Harvard Medical School and completed residency and fellowship training at UCSF. She currently serves as Vice President of SART and is past President of SREI, with editorial roles at the American Journal of Obstetrics and Gynecology and Human Reproduction.
Suitable For
Women pursuing IVF at an advanced maternal age: Dr. Baker is experienced in ovarian reserve assessment and individualized stimulation for women over 35, optimizing outcomes for every retrieval cycle.
Patients with primary ovarian insufficiency or diminished ovarian reserve: As a specialist in premature ovarian insufficiency, she provides comprehensive fertility assessment and a full spectrum of treatment options, including donor egg pathways.
Patients with repeated failed cycles: She systematically reviews prior treatment data and rebuilds protocols across ovarian response, embryo quality and endometrial receptivity to avoid repeating ineffective treatment.
Patients focused on long-term health outcomes: Her research on maternal and child health after fertility treatment ensures that care prioritizes not only immediate success but also long-term wellbeing.